BioWorld

Feb. 22, 2005

Neose Raising $28M, Planning INDs For Two Protein Products

Neose Technologies Inc. is raising $28 million in a public offering to fund ongoing development activities, including preclinical and clinical evaluation of its two lead protein products. (BioWorld Today) Read More

FDA Committee Members Vote To Let Vioxx Return To Market

Combinatorial Approach Flies Against Huntington's Disease

CNS Research Deal With Otsuka Gives Galenea Room To Grow

Holiday notice

Acusphere Raises $41.5M Via Sale Of Convertible Shares

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 8, 2026.

New York University identifies new analogues of mannose-6-phosphate

BioWorld Science

New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

Bial-Portela discovers new OX1 receptor antagonists

BioWorld Science

Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...

Woman taking medication for mental illness

Autobahn on the fast track with bipolar thyroid agonist

BioWorld

Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...